A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
NCT04289987 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 134
Last updated 2024-02-13
Summary
The purpose of this study is to evaluate the efficacy and safety of the investigational medicinal product CVI-HBV-002.
Conditions
- Hepatitis B, Chronic
Interventions
- BIOLOGICAL
-
CVI-HBV-002
Investigational Product
- BIOLOGICAL
-
Normal Saline(placebo)
Investigational Product
Sponsors & Collaborators
-
CHA Vaccine Institute Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Joon Hyeok Lee · Samsung Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-19
- Primary Completion
- 2023-12-04
- Completion
- 2023-12-04
Countries
- South Korea
Study Locations
More Related Trials
-
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
NCT01813487 ·Status: COMPLETED ·Phase: NA
-
Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B
NCT01242787 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
NCT07051187 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B
NCT03491553 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion
NCT07204236 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
NCT03519113 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection
NCT01480492 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
NCT07179653 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
NCT05686759 ·Status: RECRUITING ·Phase: PHASE3
-
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
NCT00467545 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B
NCT01189656 ·Status: UNKNOWN ·Phase: PHASE2
-
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection
NCT01594905 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
NCT02496897 ·Status: COMPLETED ·Phase: PHASE1
-
Tenofovir Combination or Mono-therapy for MDR CHB
NCT03597633 ·Status: UNKNOWN
-
Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B
NCT07282249 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects
NCT03020745 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
NCT02956850 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea
NCT01776814 ·Status: UNKNOWN
-
Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B
NCT01595685 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
NCT01590654 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
NCT03801798 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
NCT00869778 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment
NCT03615066 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
NCT02533544 ·Status: COMPLETED
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
NCT07024641 ·Status: RECRUITING ·Phase: PHASE1